[Multicenter validation study of a questionnaire assessing patient satisfaction with and acceptance of totally-implanted central venous access devices].
Fiche publication
Date publication
avril 2015
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr RANGEARD Olivier
Tous les auteurs :
Marcy PY, Dahlet C, Brenet O, Yazbec G, Dubois PY, Salm B, Fouche Y, Mari V, Montastruc M, Lebrec N, Ancel B, Paillocher N, Dupoiron D, Rangeard O, Michel C, Chateau Y, Ettaiche M, Ferrero JM, Chamorey E
Lien Pubmed
Résumé
Most cancer patients require a totally-implanted central venous access device (TIVAD) for their treatment. This was a prospective, multicenter, open study to: (i) develop and validate a French-language questionnaire dubbed QASICC (Questionnaire for Acceptance of and Satisfaction with Implanted Central Venous Catheter) assessing patient's satisfaction with and acceptance of their TIVAD; (ii) develop a mean score of patient's acceptance and satisfaction; (iii) look for correlation between QASICC score and TIVAD patient/tumor pathology/device characteristics.
Mots clés
Cancer, Cathéter veineux central, Chambre à cathéter implantable, Dispositif veineux implantable, Neoplasms, Oncologie, Patient acceptance of health care, Patient's satisfaction, Qualité de vie, Questionnaire, Questionnaires, Satisfaction, Totally-implanted central venous access device, Validation studies, Vascular access devices, Venous catheter, Voie veineuse centrale, Étude de validation
Référence
Bull Cancer. 2015 04;102(4):301-15